1400707-07-4

Basic information

• Product Name: (3R,4S)-4-cyclopropylamino-3-fluoro-piperidine-1-carboxylic acid benzyl ester
• Synonyms: (3R,4S)-4-cyclopropylamino-3-fluoro-piperidine-1-carboxylic acid benzyl ester
• CAS NO: 1400707-07-4
• Molecular Weight: 292.353
• Mol File: 1400707-07-4.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: (3R,4S)-4-cyclopropylamino-3-fluoro-piperidine-1-carboxylic acid benzyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (3R,4S)-4-cyclopropylamino-3-fluoro-piperidine-1-carboxylic acid benzyl ester(1400707-07-4)
• EPA Substance Registry System: (3R,4S)-4-cyclopropylamino-3-fluoro-piperidine-1-carboxylic acid benzyl ester(1400707-07-4)

Safety Data

• Hazardous Substances Data: 1400707-07-4(Hazardous Substances Data)

Upstream product

• 845256-59-9 benzyl 3-fluoro-4-oxopiperidine-1-carboxylate 
• 765-30-0 Cyclopropylamine 

Relevant articles and documents

N-CYCLOPROPYL-N-PIPERIDINYL-AMIDES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND USES THEREOF

The present invention relates to compounds of general formula (I), wherein R1, LP, LQ, (Het)Ar, m and n are as defined in the application, which have valuable pharmacological properties, and in particular bind to the GPR1 19 receptor and modulate its activity.

N-CYCLOPROPYL-N-PIPERIDINYL-AMIDE DERIVATIVES AND THEIR USE AS GPR119 MODULATORS

The present invention relates to compounds of general formula I wherein R1 is selected from a group consisting of -CH2-Ra, wherein Ra denotes C1-6-alkyl optionally mono- or polysubstituted with fluorine, or C3-6- cycloalkyl optionally mono- or polysubstituted with fluorine and optionally substituted with a group selected from among CH3, CF3, and CHF2, and Lp, (Het)Ar1, (Het)Ar2 and n are as defined in the application, which have valuable pharmacological properties, and in particular bind to the GPR119 receptor and modulate its activity.

N-CYCLOPROPYL-N-PIPERIDINYL-AMIDES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES THEREOF

The present invention relates to compounds of general formula (I), wherein R1, LP, HetAr1, (Het)Ar2 and n are as defined in the application, which have valuable pharmacological properties, and in particular bind to the GPR119 receptor and modulate its activity.